Stanniocalcin 2‐Induced Autophagy Confers Resistance of Lung Cancer Cells to EGFR Inhibition via the ERK /Beclin 1 Signaling
Cancer Medicine · 2026
DOI: 10.1002/cam4.71874 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Yi-Nan Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Autophagy, Glycoproteins, Lung Neoplasms, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Science and Technology, Taiwan, National Taiwan University Hospital, National Science and Technology Council.
Abstract (Originalsprache)
Background
Although epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) are effective in treating NSCLC with EGFR mutations, the development of resistance limits their long‐term efficacy. Autophagy has been implicated as a potential mechanism behind this acquired resistance. This study aims to investigate the role of Stanniocalcin 2 (STC2) in mediating autophagy and its contribution to EGFR TKI resistance.
Methods
STC2 expression was manipulated to examine its effects on autophagy and EGFR TKI resistance both in vitro and in vivo. Autophagic activity was assessed by measuring LC3B‐II expression levels, the number of LC3 puncta, and the accumulation of autophagic vacuoles. Pharmacological inhibitors and small interfering RNA (siRNA) were used to assess whether the regulatory relationship between STC2 and Beclin 1 was involved in STC2‐mediated autophagy and EGFR TKI resistance.
Results
Here, we found that STC2 was associated with increased autophagic activity, as evidenced by elevated LC3B‐II levels, enhanced LC3 puncta formation, and increased accumulation of autophagic vacuoles. Conversely, STC2 knockdown resulted in reduced autophagic activity. We identified that STC2 is associated with ERK1/2 activation and Beclin 1–related autophagic activity. Importantly, inhibiting autophagy reversed the resistance to EGFR TKIs induced by STC2, as demonstrated in vitro and in vivo xenograft mouse models.
Conclusion
These findings suggest that STC2 appears to promote cytoprotective autophagy, and targeting the STC2‐associated ERK/Beclin 1 signaling axis may offer a promising strategy to overcome resistance to EGFR TKIs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
- Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
- Department of Biomedical Sciences, Da-Yeh University, Changhua, Taiwan.
- Department of Internal Medicine, National Taiwan University Cancer Center, Taipei, Taiwan.
ORCID-Profile: Tzu-Hua Chang
Förderung
- Ministry of Science and Technology, Taiwan
- National Taiwan University Hospital
- National Science and Technology Council
Zitieren
APA
Liu, Y. N., Chen, Y. L., Tsai, M. F., Wu, S. G., Chang, T. H., Tsai, T. H., & Shih, J. Y. (2026). Stanniocalcin 2‐Induced Autophagy Confers Resistance of Lung Cancer Cells to EGFR Inhibition via the ERK /Beclin 1 Signaling. Cancer Medicine. https://doi.org/10.1002/cam4.71874
Vancouver
Liu YN, Chen YL, Tsai MF, Wu SG, Chang TH, Tsai TH, et al. Stanniocalcin 2‐Induced Autophagy Confers Resistance of Lung Cancer Cells to EGFR Inhibition via the ERK /Beclin 1 Signaling. Cancer Medicine. 2026. doi:10.1002/cam4.71874
BibTeX
@article{Liu2026,
author = {Liu, Yi-Nan and Chen, Yi-Ling and Tsai, Meng-Feng and Wu, Shang-Gin and Chang, Tzu-Hua and Tsai, Tzu-Hsiu and Shih, Jin-Yuan},
title = {Stanniocalcin 2‐Induced Autophagy Confers Resistance of Lung Cancer Cells to EGFR Inhibition via the ERK /Beclin 1 Signaling},
journal = {Cancer Medicine},
year = {2026},
doi = {10.1002/cam4.71874}
}
EUVIMED